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ABSTRACT 
A clinical intervention known as ‘bridging to transplant’, in which a patient is placed on life-sustaining 
support, can be used to increase the chance of an individual surviving until a donor heart becomes 
available. However, the impact of this on other patients on the waiting list and the wider implications for 
the resourcing of cardiac units remains unclear. Initial insights have previously been generated using a 
birth-death queuing model, but this model did not incorporate realistic donor-recipient assumptions 
regarding blood type and weight. Here we report on a complementary simulation study that examined 
how estimates from the analytical model might change if organ matching were better taken into account. 
Simulation results showed that system metrics changed substantially when recipient donor compatibility 
was modelled. However, the effects of blood type compatibility were countered by that of weight 
compatibility and when combined, these have a relatively small net effect on results. 
1 INTRODUCTION 
Depending on the severity of their cardiac failure, children awaiting a heart transplant in the UK are 
registered either as urgent or non-urgent, with priority for compatible hearts given to those with urgent 
status. Due to the short life expectancy of these children, the rarity of pediatric donor hearts, and the 
necessity for donor-recipient compatibility according to weight and blood type, there can be a lack of 
available donor organs or of suitable recipients when donor organs do become available (Andrews et al. 
2008; Suddaby 1999). As a result, patients may die waiting for a heart and yet some donor hearts go 
unused (Goldman et al. 2003; McMahon et al. 2003). 
To increase both the chance of an individual surviving to transplant and the use of donor organs, a 
clinical intervention known as ‘bridging to transplant’ has been introduced whereby the patients awaiting 
a donor heart are admitted to hospital and given life-sustaining support (Fiser et al. 2003; Gajarski et al. 
2003). In the UK, such a program of bridging to heart transplant was introduced in 1998 (Goldman et al. 
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2003; McMahon et al. 2003). However, bridging by no means guarantees survival to transplant, is 
financially costly (Brown et al. 2009) and has implications for the use of scarce resources in high-
intensity care units. In decisions regarding bridging strategy, the potential benefit to bridged patients 
would ideally be considered alongside the other implications, including the impact on transplant patients 
that are not bridged and the extent to which prolonged bed-occupancy affects other cardiac services. A 
mathematical model that relates the key variables of this complex problem and has clinical face validity 
could potentially be a useful tool for informing decision makers.  
With this in mind, a queuing theoretic model of this system using birth-death analysis theory has been 
developed (Crowe et al. 2011). Illustrative results from this model have provided initial insights of 
interest to clinicians and managers involved in the UK pediatric heart transplant bridging program. The 
model was deliberately chosen to be simple and does not incorporate donor-recipient compatibility 
requirements related to blood type nor realistic weight-matching criteria. Adding such requirements 
considerably complicates the queuing theory equation and, thus far, an analytical solution has not been 
found. However, the impact of this simplification on the quantitative forecasts of the model, and therefore 
how clinically valid the model would be for use in informing decisions regarding future bridging strategy, 
is unclear.  
In this study we used simulation to examine the importance of taking full organ matching criteria into 
account when assessing the overall effects of bridging and to detect whether this gives rise to gross errors.  
We note that although simulation has been used to address many issues surrounding liver (Howard 2001; 
Pritsker 1998; Ratcliffe et al. 2001; Thompson et al. 2004), renal (Abellan et al. 2006; Zenios et al. 2000) 
and cardiac (van den Hout et al. 2003) transplant waiting lists, to the best of our knowledge simulation or 
analytical methods have not been applied to the specific problem of bridging to heart transplantation in 
pediatric patients, other than the birth-death queuing model (Crowe et al. 2011). 
2 MODELING THE PEDIATRIC HEART TRANSPLANT WAITING LIST PROGRAM IN 
THE UK 
2.1 Birth-death queuing model 
Previous work by the authors (Crowe et al. 2011) concerned modeling pediatric heart transplant waiting 
lists using simple queuing theory. Within this analysis, the referral of patients to a transplant waiting list 
was assumed to follow a Poisson process. The clinical pathways followed by patients are summarized in 
Figure 1. A specified proportion of these patients were assumed to be assigned, at random, to an urgent 
waiting list, the remaining to a non-urgent list. A given percentage of patients on the urgent list were 
assumed to warrant bridging on clinical grounds and, of those, a specified proportion was assumed to be 
assigned to bridging. The latter proportion was the mechanism used by which one could investigate a 
range of policy options, from zero bridging to the current UK practice of bridging all patients that meet 
the clinical indications. 
Four classes of potential recipients were considered: non-urgent list patients and three classes of 
urgent cases, including those deemed to warrant bridging (partitioned according to whether or not they 
were assigned to it) and those judged not to warrant bridging.  It was also assumed that patients do not 
move between classes. It was assumed that, in the absence of a transplant, patients’ life expectancy 
following referral are negative exponentially distributed, the mean rates of death on the waiting list 
dependent upon the patient class.  
Donor heart arrivals were assumed to follow a Poisson process. In reality, patients only receive donor 
hearts that are blood type and weight compatible. However, within this queuing model, two simplifying 
assumptions were made. Firstly, it was assumed that there are no donor-recipient matching conditions 
related to blood type. Secondly, recipients and patients were split into three separate weight groups (<10 
kg, 10-30 kg and >30kg) and it was assumed that patients may only receive hearts from within the same 
weight group.  
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Figure 1: Flow diagram illustrating the four patient classes: non-urgent list patients, urgent list patients 
not warranting bridging, urgent list patients warranting bridging but not bridged and urgent list bridged 
patients. The proportion of patients warranting bridging that are bridged is the mechanism used to 
investigate possible bridging policy options. 
In the allocation of donor hearts, priority was assumed to be given to patients on the urgent list and 
allocated at random within the urgent patient classes. In the absence of patients on the urgent waiting list, 
donor hearts were assumed to be assigned to patients on the non-urgent list at random. 
Given this model structure, an analytical approach based on birth-death analysis was used to establish 
expressions for various steady state quantities such as the expected transplant rate and death rates for 
urgent and non-urgent patients.  
Under a further assumption that all urgent patients spend their entire wait in hospital whilst non-
urgent patients spend their entire wait at home, an expression for the expected number of hospital bed-
days per year associated with a given bridging policy was also derived. Details of this approach and 
illustrative results generated with parameter values estimated from retrospective data from Great Ormond 
Street Hospital, London, are presented elsewhere (Crowe et al. 2011). The parameter values are 
reproduced for ease of reference in Tables A1 and A2 in the Appendix. 
2.1.1 Limitations of the birth-death queuing model; donor-recipient matching 
In real life, it is not the case that any donor heart is compatible with any recipient and there are important 
considerations regarding weight and blood type compatibility. Current stated practice in the UK for 
donor-recipient matching by weight is to allow transplantation of hearts from a donor up to three times 
the recipient’s weight but weighing no less than them. In general, matching by blood type must follow the 
donor-recipient ABO-compatibility rules set out in Table 1. However, newborn infants have relatively 
immature immune systems and low blood-group antigens, which means they may receive a heart 
transplant from a donor in an ABO-incompatible blood group (Irving et al. 2010; West et al. 2001). 
Given that the absence of realistic donor-recipient compatibility rules in the birth-death model is an 
obvious deficiency, it is of interest to examine how far this absence impacts on its output metrics and 
hence the insights that can be drawn from these. In the remainder of the paper, we investigate the relative 
size of the effects of the blood type and weight matching simplifications and the extent of their combined 
impact on the results of the birth-death model. We do this with the motivation of better understanding the 
potential for using quantitative forecasts generated from the birth-death model to inform policy. 
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Table 1: Contingency table indicating whether a given recipient and donor are tissue matched. 
Donor blood group O A B AB 
R
ec
ip
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t 
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ro
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p
 
O Yes No No No 
A Yes Yes No No 
B Yes No Yes No 
AB Yes Yes Yes Yes 
2.2 Simulation 
A computer simulation model was developed in which patient and donor heart arrivals were sampled 
from Poisson distributions, with mean rates the same as those in the birth-death model (Table A1, 
Appendix). The patients were categorized according to the classes defined in the birth-death model 
(Figure 1) and both patients and donors were assigned to one of three weight groups (<10kg, 10-30 kg 
and >30kg), again using the proportions adopted in the birth-death model (Table A1, Appendix). Within 
the simulation, in addition to being assigned a weight band, donors and patients were assigned a 
‘continuous weight’ sampled from a uniform distribution within their assigned weight group, i.e. from a 
uniform distribution for 5-10kg, 10-30kg and 30-80kg (where the lower limit of 5kg and upper limit of 
80kg were assumed to be reasonable cut-off points). Donor hearts and patients were also assigned a blood 
type upon arrival, sampled at random with the proportions in each blood group set to those of the general 
UK population: O (44%), A (42%), B (10%) and AB (4%) (NHS Blood and Transplant 2011). 
Upon arrival, patients were assigned an expected survival time in the absence of transplant, sampled 
from a negative exponential distribution with mean death rate dependent on their patient class and taking 
the values adopted in the birth-death model (Table A2, Appendix). As in the birth-death model, priority 
was given to patients on the urgent list when allocating hearts. If there was more than one suitable patient 
on the same waiting list then the heart was offered on a first-come-first-served basis. It was assumed that 
there was no prioritization between classes within the urgent list (i.e. between bridged and not-bridged 
urgent patients).  
Four simulation scenarios were considered for the allocation of hearts in terms of donor-recipient 
matching, as described in Table 2. Within these scenarios, two forms of weight matching were 
considered. First, referred to as ‘group weight matching’, where there is a requirement for the donor and 
recipient both to have a weight within the same range from 5-10kg, 10-30kg and 30-80kg. This is the 
same rule assumed for the birth-death model. The second form of weight matching uses the ‘continuous 
weight’ property of recipients and donors. This form of weight matching requires the ratio of donor to 
recipient weight to be in the range (McMahon et al. 2003; Suddaby 1999), i.e., a heart may be offered to a 
patient from a donor up to three times their weight but weighing no less than the patient, which is 
currently the stated UK practice. Two of the simulation scenarios include blood type matching, for which 
donor and recipients must be ABO-compatible.  
A time-slicing simulation approach (Robinson 2004) was implemented in which all simulation events 
(referrals of patients and heart donations, matching, deaths and transplantation) were deemed to take place 
at weekly intervals. Each simulation run concerned the operation of the system over a five year period, 
following a two year ‘warm-up period’ (selected using Welch’s graphical method) to allow steady state to 
be approached. Output metrics include the average annual number of transplants and deaths per year 
(from either urgent and non-urgent lists), the average patient waiting time to transplant or death and the 
average number of bed-days used by urgent list patients. In order to estimate the mean number of bed-
days per year associated with a given bridging policy, it was assumed that all urgent patients spend the 
Crowe, Vasilakis, Gallivan, Fenton, and Bull 
 
entirety of their stay in hospital, while non-urgent patients wait at home (as in the birth-death model). 
Results were averaged over 100 simulation runs with upper and lower 95% prediction intervals calculated 
using the Student’s t-distribution (Robinson 2004). The number of runs was chosen after some initial 
experimentation and on the basis that the prediction intervals were adequately narrow for the purposes of 
this analysis. A different stream of random numbers was used in each run. The user interface of the 
simulation was implemented in MS Excel and the simulation engine was coded in Visual Basic for 
Applications (VBA).  
Table 2: Donor-recipient matching criteria for the four simulation matching scenarios and the birth-death 
model. 
Simulation scenario 
Donor-recipient blood 
type matching criteria 
Donor-recipient weight matching criteria 
No 
matching 
ABO-
compatible 
Both in same weight group 
(<10kg / 10-30kg / >30kg) 
Current UK 
practice a 
Group weight matching X  X  
Blood type & group 
weight matching 
 X X  
Continuous weight 
matching 
X   X 
Blood type & 
continuous weight 
matching 
 X  X 
Birth-death queuing 
model 
X  X  
a Currently in the UK, a heart may be offered to a patient from a donor up to three times their weight but 
weighing no less than them, i.e. donor to recipient weight ratio in range (McMahon et al. 2003; Suddaby 
1999). 
3 RESULTS 
In total, 2400 simulation runs produced 254 966 patient and 1 221 538 donor heart arrivals. Of the total 
number of patients, 67.1% were transplanted and 24.5% died while waiting for a suitable heart (the 
remaining were still waiting at the end of the simulation). Of the donor hearts, 14.0% were used in a 
transplantation. The estimates for the expected waiting time to transplant or death generated are presented 
in Table 3 for each of the four donor-recipient matching simulation scenarios under the strategy of 
bridging all those patients deemed to warrant bridging. 
3.1 Comparison of birth-death and simulation model 
In the following, illustrative output is presented for the different simulation models and compared with 
the birth-death model in order to investigate how the insights from this are affected by relaxing donor-
recipient matching constraints. 
3.1.1 Comparing model estimates for the annual number of transplants 
Firstly, we compare illustrative model results regarding the potential benefits of bridging. Figure 2 shows 
the mean annual number of transplants from both waiting lists (aggregated over all weight and blood type 
groups) as a function of the percentage of those patients warranting bridging that are bridged. The 
horizontal axis represents the level of bridging policy and ranges from zero to universal bridging of those 
patients deemed to warrant bridging. 
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Table 3: Simulation model estimates under different matching scenarios for the expected waiting time 
from referral to transplant or death, in weeks (with 95% prediction intervals). Also shown are the ratios of 
the expected waiting times with respect to the group weight matching scenario. These were estimated for 
a strategy of bridging all patients deemed to warrant bridging. 
Simulation scenario Expected waiting time from referral to 
transplant or death, in weeks (point estimate 
and 95% prediction interval) 
Ratio of point estimate with 
respect to group weight 
matching scenario 
Group weight 
matching 17.6 (16.6-18.5) - 
Blood type & group 
weight matching 19.5 (18.6-20.4) 1.1 
Continuous weight 
matching 5.2 (5.0-5.5) 0.3 
Blood type & 
continuous weight 
matching 7.4 (7.1-7.8) 0.4 
 
With the birth-death model, the illustrative results show, as would be expected, a clear increase in the 
mean annual number of transplants as a larger proportion of those patients warranting bridging are 
bridged. It shows an estimated additional 0.8 transplants per year under a full bridging policy compared to 
a zero-bridging policy, representing an approximately 6% increase. In the group weight matching 
scenario, which is designed to be akin to the birth-death model, this upward trend is not discernable 
within 95% prediction intervals and estimates are slightly higher for the number of transplants at each 
level of bridging policy. 
 
Figure 2: Model estimates under different matching scenarios for the mean annual number of transplants 
from both waiting lists, shown as a function of the percentage of patients warranting bridging that are 
bridged. Whiskers denote the 95% prediction intervals. 
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When more realistic matching is introduced, there is a noticeable impact (over and above the 95% 
prediction intervals) on the estimated number of transplants per year compared to the group weight 
matching scenario. When blood type matching is incorporated, the number of transplants falls by 9% on 
average across all bridging policies, whilst it increases by 26% for the continuous weight matching 
scenario. The combined impact of incorporating both blood type and continuous weight matching is an 
increase of 16% on average across all bridging policies (i.e. the percentage of patients deemed to warrant 
bridging that are bridged). 
3.1.2 Comparing model estimates for the number of deaths on the non-urgent waiting list 
We next compare the information derived from the birth-death and simulation models concerning the 
impact of bridging specifically on those patients on the non-urgent list, none of whom are bridged. Figure 
3 shows the mean annual number of deaths of patients waiting on the non-urgent list as a function of 
bridging policy. 
 
Figure 3: Model estimates under different matching scenarios for the mean annual number of deaths on 
the non-urgent list, shown as a function of the percentage of those patients warranting bridging that are 
bridged. 
Using the birth-death model, the number of deaths on the non-urgent waiting list is seen to increase as 
bridging increases, with an estimated additional 0.4 deaths (approx. 14%) per year under a full bridging 
policy compared to a zero-bridging policy. Therefore, whilst bridging increases the overall number of 
transplants from both lists (and hence reduces overall deaths) it has a negative impact on the non-urgent 
waiting list. These estimates are within the 95% prediction intervals of the group weight matching 
simulation scenario estimates. When the donor-recipient matching simplifications are changed, the 
estimated number of deaths per year increases when blood type matching is incorporated (by 12% on 
average over all bridging policies) and decreases when continuous weight matching is incorporated (by 
approximately 67% on average). The combined impact of incorporating both continuous weight and 
blood type matching is, on average across all bridging policies, a fall of 50% in the number of deaths on 
the non-urgent waiting list from the scenario akin to the birth-death model. 
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3.1.3 Comparing model estimates for the opportunity cost of bridging 
The models can be used to explore some of the wider implications of different bridging policies in terms 
of the scarce resources of cardiac units. Every bed-day used for an urgent heart transplant patient (bridged 
or not) is a bed-day that cannot be used for other patients that may need it, hence there is an opportunity 
cost associated with each bridging policy. Figure 4 shows the mean annual number of transplants at a 
given level of bridging versus the mean annual number of bed-days used for that policy (the opportunity 
cost). Each data point represents a bridging policy within the model, i.e. a percentage of those patients 
warranting bridging that are bridged. 
 
 
Figure 4: Model estimates under different matching scenarios for the mean annual number of transplants 
from both waiting lists as a function of the annual number of bed-days required to achieve that benefit. 
Moving from a policy of zero bridging to one of bridging all patients deemed to warrant it, the 
increase of 0.8 in the annual number of transplant per year comes at an additional opportunity cost of 
approximately 75 bed-days according to the birth-death model. In the group weight matching simulation 
scenario the additional opportunity cost is approximately 80 bed-days, although the absolute number of 
bed-days associated with either bridging policy is higher than in the birth-death model. 
When the donor-recipient matching simplifications in the group weight matching simulation scenario 
are relaxed, the additional opportunity cost of bridging is approximately 90, 25 and 30 bed-days for the 
blood type, the continuous weight, and the continuous weight and blood type matching scenarios 
respectively. 
4 DISCUSSION  
The previously developed birth-death queuing model of pediatric heart transplant waiting lists (Crowe et 
al. 2011) was deliberately chosen to be simple as it allowed key relationships to be explored analytically, 
which was appealing in a non-linear system with multiple contributing factors. Further, the queuing 
theory model could be solved exactly with no need for approximation. Illustrative results offered some 
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initial insights regarding the inter-relationships of the system that were of interest to clinicians and 
managers.  
However, it was acknowledged that the implications of the donor-recipient matching simplifications, 
which were necessary for reasons of mathematical tractability, would need to be understood and 
potentially addressed before such a model could directly aid policy-making. The computer simulation 
model we subsequently developed was designed to generate the same output metrics as the birth-death 
model under a more flexible framework that explicitly incorporates broader donor-recipient compatibility 
criteria. Hence it could be used to directly investigate the impact of relaxing simplifications regarding 
compatibility.  
Overall, we found that changing from group weight matching to more realistic continuous weight 
matching in the simulation led to a more appreciable (and opposing) impact on the simulation output 
metrics than the incorporation of blood type matching. When combined, the effects partially cancelled 
each other to give a relatively small (but not-negligible) net increase in transplant levels and net decreases 
in the number of deaths on the non-urgent list and bed-days used, suggesting a tendency toward 
pessimistic forecasts by the original birth-death model. This outcome cannot be generalized however, as it 
may depend on the nature of the matching algorithms and the values of the input parameters.  
Interestingly, the group weight matching scenario, based on exactly the same assumptions as the 
birth-death model, did not forecast the use of bridging leading to an increase in expected annual rates of 
transplantations as clearly as the birth-death model does (Figure 2). Within the simulation, time is 
regarded as discrete and perhaps for such a discrete stochastic process, were it soluble, the increase in 
annual transplant rates truly is so small that it cannot be detected. Another possibility concerns the nature 
of the queuing theory underlying transplantation: stochastic analysis of waiting list dynamics has proved 
difficult because it involves extreme combinatorial complexity (Gallivan and Crowe 2011). Nevertheless, 
the simulation results across all scenarios do not contradict the trends established from the birth-death 
model.  
In our simulation we sampled weights, first by sampling a weight range from 5-10, 10-30, 30-80 kg, 
then a weight within this range assuming a uniform distribution. While this has some computational 
advantages in the context of the study, simulation allows the inclusion of alternative options such as 
sampling from non-uniform distribution or even a continuous weight distribution over the whole range. 
The nature of such sampling undoubtedly has some effect on the metrics that the simulation forecasts, so 
it is unwise to treat these forecasts as precise. We have also assumed that both patient and donor weights 
are in the range 5-80 kg, which is not always the case.  
The simulation results for the most realistic scenario with blood type and continuous weight matching 
support the insights established from the birth-death model, which is encouraging in terms of supporting 
the validity of insights drawn from it. In this manner, the complementary use of both analytical methods 
and simulation provides a means by which to understand better the validity and usefulness of modeling to 
inform policy decisions in this area. In future work, a combined approach such as this could also be used 
to assess and, if needs be, address the limitations of the birth-death model in modeling changes in 
patients’ urgency status, weight and bridging circumstances. 
5 CONCLUSIONS  
We have developed a computer simulation in order to investigate aspects of the bridging to pediatric heart 
transplantation program within the UK. Specifically, we have used this to evaluate the implications of 
simplifications around donor-recipient compatibility that were integral to an existing model based on 
birth-death queuing theory. Although incorporating these features into the analytical model was 
unattainable, computer simulation allowed us to do so in a straightforward manner, both conceptually and 
in its implementation (coding). On the other hand, adoption of a simulation approach was not without 
disadvantages. There are technical issues concerning what ‘warm up’ period to use, how many simulation 
runs to perform and what time slice to adopt. Such choices may require considerable experimentation and 
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are thus computationally expensive and, often, require reliance on subjective opinion guided by 
experience.  In any case, embedding a simulation model into a software tool would pose additional 
challenges in the implementation phase and, perhaps more importantly, in the usability of the resulting 
software tool. 
The simulation showed a small, but non-negligible net impact on various system metrics when both 
blood type and weight compatibility simplifications were changed to more realistic assumptions, 
suggesting the original birth death model is perhaps somewhat pessimistic in its forecasts, but certainly 
not wildly inaccurate. However, the simulation results did not contradict the birth-death model in relation 
to the impact of bridging policy on the various system metrics. Although neither the analytical nor the 
simulation model are currently in use, we think that by engaging closely with relevant clinicians in the 
modelling process, we highlighted a number of key issues that are very relevant in the operation of the 
real life system and provided useful insights into the key relationships associated with pediatric cardiac 
transplant services. 
Despite the individual limitations of each model, we have demonstrated that the complementary use 
of analytical and simulation methods provides a means by which to understand better the relationships in 
this problem, which could be useful in informing policy decisions in this area. Added benefits of 
complementary use of the two methods include the increased face validity of the models to clinicians and 
the increased confidence of the analytical team in the results. On the other hand, longer study 
development and execution times, limited availability of analytical and programming expertise, and 
increased computational complexity may dissuade the complementary use of the two methods.  
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A APPENDIX 
The input parameter values of the birth-death model shown in Tables A1 and A2 were estimated from 
retrospective data for patients at Great Ormond Street Hospital, as described elsewhere (Crowe et al. 
2011). These parameter values were also used within the simulation model. 
Table A1: Mean arrival rates of donor hearts and patients and the proportions in each patient class (by 
weight group).  
Weight 
group 
Mean 
patient 
arrival rate 
(per year) 
Proportion 
of patients 
on urgent 
waiting list 
Proportion of 
patients on urgent 
list that are deemed 
to warrant bridging 
Mean donor 
heart arrival 
rate (per year) 
≤10kg 6.6 0.43 0.32 2.5 
10-30kg 7.35 0.37 0.56 5.2 
≥30kg 6.6 0.5 0.55 94.3 
Table A2: Mean annual death rates on the waiting list of patients by class (by weight group).  
Weight 
group 
Death rate on waiting list (per year) 
Non-urgent 
list patients 
Urgent 
bridged 
patients 
Urgent patients 
warranting bridging 
that are not bridged 
Urgent patients 
not warranting 
bridging 
≤10kg 0.9 8.1 26 10.4 
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10-30kg 0.4 3.7 26 4.7 
≥30kg 0.9 8.4 26 10.8 
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